JPMorgan Chase & Co. reduced its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 73.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 816,209 shares of the company's stock after selling 2,310,398 shares during the period. JPMorgan Chase & Co. owned about 0.88% of Acadia Healthcare worth $32,363,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also modified their holdings of ACHC. State Street Corp boosted its holdings in Acadia Healthcare by 3.5% during the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company's stock valued at $178,811,000 after acquiring an additional 95,613 shares during the period. Geode Capital Management LLC lifted its position in shares of Acadia Healthcare by 0.9% during the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company's stock worth $102,320,000 after purchasing an additional 14,197 shares in the last quarter. Stephens Investment Management Group LLC boosted its stake in shares of Acadia Healthcare by 24.9% in the fourth quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company's stock valued at $58,490,000 after purchasing an additional 294,210 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Acadia Healthcare by 9.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,234,223 shares of the company's stock valued at $48,937,000 after purchasing an additional 107,162 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. lifted its holdings in Acadia Healthcare by 38.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,064,455 shares of the company's stock worth $42,206,000 after buying an additional 295,515 shares in the last quarter.
Acadia Healthcare Stock Down 3.4 %
ACHC traded down $0.93 on Friday, reaching $26.15. The company's stock had a trading volume of 2,200,198 shares, compared to its average volume of 1,471,232. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a fifty-two week low of $25.41 and a fifty-two week high of $82.41. The stock has a 50 day moving average of $33.22 and a two-hundred day moving average of $41.19. The company has a market capitalization of $2.43 billion, a price-to-earnings ratio of 8.57, a P/E/G ratio of 1.46 and a beta of 1.13.
Analysts Set New Price Targets
ACHC has been the subject of several research reports. Barclays downgraded shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Bank of America lowered their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. KeyCorp reduced their price target on Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Monday, March 3rd. StockNews.com downgraded Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. Finally, Royal Bank of Canada reduced their target price on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $50.39.
Check Out Our Latest Report on Acadia Healthcare
About Acadia Healthcare
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
